New Washington law 2SSB 5195 went into effect on Jan. 1, 2022. It requires hospital emergency departments and many behavioral health settings (e.g., inpatient psychiatric units, psychiatric hospitals) to dispense or distribute opioid overdose reversal medication (e.g., naloxone) to patients at risk of an opioid overdose for individual use after discharge.
WSHA will host the Opioid Overdose Reversal Medication Roundtable: A Discussion on 2SSB 5195 Implementation from 12:00–1:30 p.m. on March 16, 2022. We will provide updates from the current legislative session, hear from community partners and discuss implementation with a panel of hospital representatives from across the state. Please register here and contact Brittany Weiner at email@example.com with any questions.
WSHA also issued a bulletin on this bill last fall and held a webinar in November 2021 to review the requirements of this bill.